These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19269774)

  • 1. Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients.
    Dewan MZ; Takada M; Terunuma H; Deng X; Ahmed S; Yamamoto N; Toi M
    Biomed Pharmacother; 2009 Nov; 63(9):703-6. PubMed ID: 19269774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.
    Srivastava R; Aggarwal R; Bhagat MR; Chowdhury A; Naik S
    J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
    Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of autoplasma of patients with breast cancer on the functional activity of natural killer cells and adhering mononuclear cells in peripheral blood in vitro].
    Andrianov IG; Katashkova TN
    Eksp Onkol; 1989; 11(5):64-6. PubMed ID: 2791959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
    Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulation of natural killer activity of human peripheral blood mononuclear cells against prostate tumor cell line.
    Sheikhi A; Saadati K; Salmani R; Yahaghi N; Sheikhi A; Siemens DR
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):700-8. PubMed ID: 21425925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of host immune response in breast cancer patients.
    Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
    Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
    Uchida A; Kolb R; Micksche M
    J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
    Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A
    Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells.
    Nielsen LR; Kimose HH; Linnet L; Møller NP; Bukh A
    J Clin Lab Immunol; 1989 Jun; 29(2):71-7. PubMed ID: 2632804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-related hormonal suppression of natural killer activity does not show menstrual cycle variations: implications for timing of surgery for breast cancer.
    Garland M; Doherty D; Golden-Mason L; Fitzpatrick P; Walsh N; O'Farrelly C
    Anticancer Res; 2003; 23(3B):2531-5. PubMed ID: 12894537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma.
    Shirai M; Watanabe S; Nishioka M
    Hepatogastroenterology; 1990 Oct; 37(5):465-8. PubMed ID: 2174825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
    Pislarasu M; Oproiu A; Taranu D; Herberman RB; Sulica A
    Cancer Res; 1988 May; 48(9):2596-603. PubMed ID: 3356020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional activity of the natural killers and macrophages in patients with breast tumors].
    Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
    Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
    Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
    Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma.
    Mocchegiani E; Ciavattini A; Santarelli L; Tibaldi A; Muzzioli M; Bonazzi P; Giacconi R; Fabris N; Garzetti GG
    Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.